Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

The Future Fund – What's Next?

Summary

Speakers

Sophie C. McGrath

Adam Thatcher

Related Content

Series 2: How to Determine Your Risk Category and What It Means to Be ‘High-Risk’

Does the EU AI Act Classify Your AI System as High Risk?

Antitrust & Competition Technology 2023 Year in Review

The New UK Public Offers Regime: Three Key Takeaways and Next Steps

In Continuing Efforts to Incentivize Self-Disclosures and Cooperation, DOJ Announces Pilot Program to Pay Criminal Whistleblowers

Digital Markets Act: Mandatory Compliance for Big Tech Companies

Healthcare Experts See Promising Signs of Rebound in M&A and IPO Activity

The EU AI Act Is (Almost) Here. What It Means for Your Business

Pepper Completes $30 Million Series B Financing

What Tech Companies Need to Know: State of Tech M&A Panel

Goodwin Welcomes Private Investment Funds Partner Alicja Biskupska-Haas in New York

Delphia Therapeutics Completes $67 Million Series A

Amid Continued Growth in the United Kingdom, Goodwin Relocates London Office to Iconic Paternoster Square

Camion Raises €2.7 Million in Pre-Seed Round

Sound Bioventures joins £19 Million Financing of Theolytics

MS&AD Ventures invests in Artificial Labs’ Series A+ Round

Technology

Life Sciences

Life Sciences Europe